Formulation and Evaluation of Nelfinavir Extended Release Trilayer Matrix Tablets by Design of Experiment
|
|
- Osborne Byrd
- 5 years ago
- Views:
Transcription
1 Rangu and Gande: Formulation and Evaluation of Nelfinavir Extended Release Trilayer Matrix Tablets by Design of International Journal of Pharmaceutical Sciences and Nanotechnology Research Paper Formulation and Evaluation of Nelfinavir Extended Release Trilayer Matrix Tablets by Design of Experiment Rangu Nirmala* and Gande Suresh Department of Pharmaceutics, Mewar University, NH-79, Chittorgarh , Rajasthan, India. Received July 23, 2018; accepted August 10, 2018 Volume 11 Issue 5 September October 2018 MS ID: IJPSN NIRMALA ABSTRACT The present study was aimed to develop once-daily controlled release trilayer matrix tablets of nelfinavir to achieve zero-order drug release for sustained plasma concentration. Nelfinavir trilayer matrix tablets were prepared by direct compression method and consisted of middle active layer with different grades of hydroxypropyl methylcellulose (HPMC), PVP (Polyvinyl Pyrrolidine) K-30 and MCC (Micro Crystalline Cellulose). Barrier layers were prepared with Polyox WSR-303, Xanthan gum, microcrystalline cellulose and magnesium stearate. Based on the evaluation parameters, drug dissolution profile and release drug kinetics DF8 were found to be optimized formulation. The developed drug delivery system provided prolonged drug release rates over a period of 24 h. The release profile of the optimized formulation (DF8) was described by the zero-order and best fitted to Higuchi model. FT-IR studies confirmed that there were no chemical interactions between drug and excipients used in the formulation. These results indicate that the approach used could lead to a successful development of a controlled release formulation of nelfinavir in the management of AIDS. KEYWORDS: Nelfinavir; HPMC; Polyox WSR-303; Xanthan gum; Geomatrix Technology. Introduction Oral ingestion has long been the most convenient and commonly employed route of drug delivery due to its ease of administration and flexibility in the design of the dosage form. There are many ways to design modified release dosage forms for oral administration and one of them is multi layered matrix tablet. One to three layer matrix tablets is a drug delivery device, which comprises a matrix core containing the active solute and one or more barriers incorporated during tableting process (Colombo et al., 1990). The barrier layers delay the interaction of active solute with dissolution medium, by limiting the surface available for the solute release and at the same time controlling solvent penetration rate (Conte et al., 1993; Qui et al., 1998). Hydrophilic polymers have been given considerable attention in the formulation of controlled release drug delivery systems for various drugs. HPMC K4M, HPMC K15M are a few representative examples of the hydrophilic polymers that have been extensively used in the formulation of controlled release systems (Gohel et al., 2007). Guar gum is soluble in water, it swells in gastric fluid to produce a highly viscous layer around the tablet through which the drug can slowly diffuse (Tobyn et al., 1996) and is used for the fabrication of matrices with uniform drug release characteristics (Talukdar et al., 1998; Talukdar et al., 1993). Regarding geomatrix technology, there have been different approaches to achieve zero-order drug release from dosage forms for sustained plasma concentration. Among different approaches to achieve zero-order release from hydrophilic matrix technologies, multilayer matrices have been widely evaluated and developed for commercial products under the trade name of Geomatrix. The technology makes use of bilayer or trilayer tablets to modulate the release and to achieve constant release (Wen and Park 2010). Nelfinavir mesylate (NFV) is an anti-viral drug, used in the treatment of Acquired Immunodeficiency Syndrome (AIDS). Poor oral bioavailability and shorter half-life (3.5 5 h) remain a major clinical limitation of nelfinavir leading to unpredictable drug bioavailability and frequent dosing. In this context, the objective of the present study was to formulate nelfinavir control release trilayer tablets by Geomatrix technology which can increase the oral bioavailability of sustained release of the drug. Materials and Methods Materials and Reagents Nelfinavir pure drug was generous gift from Optimus Generics Ltd., Hyderabad, India. PVP K 30, Microcrystalline cellulose, HPMC K 4 M, HPMC K 15 M was obtained from Rubicon labs, Mumbai. Polyox WSR 303 was obtained from Aurobindo Pharma Ltd., Hyderabad and Xanthan Gum was gifted from MSN Labs Ltd. Hyderabad. All other chemicals used were of analytical grade. 4259
2 4260 Int J Pharm Sci Nanotech Vol 11; Issue 5 September October 2018 Formulation and Evaluation Methods Formulation of Controlled Release Nelfinavir Trilayer Matrix Tablets The trilayered matrix tablets of Nelfinavir were prepared by direct compression method. The first step in the formulation was to develop the middle active layer so as to give at least 90% drug release during 12 hours. The release profile of this layer might not be of constant rate type but would be preferably of constantly falling rate type. This layer would then be sandwiched between barrier layers (Upper & Lower layers) so as to continue the drug release for 24 h (Derakhshandeh and Soleymani, 2010). Preparation of Middle Active Layer of Nelfinavir Trilayered Tablets Twenty-seven formulations (F1-F27) for active layer were prepared by direct compression method using 3 3 Response surface method (3 variables and 3 levels of polymers) by using Design of experiment software with polymers like different HPMC grades and Guar gum. All the formulations were varied in concentration of polymers, magnesium stearate constituted in all the formulations. These materials were screened through #60 and mixed together in motor by using pestle. Final mixtures were compressed by using 12 mm diameter flat punches on a sixteen-station rotary tablet press. Formulation trials of active layer were depicted in Table 1. The prepared tablets were subjected to dissolution studies (Potturi et al., 2015). TABLE 1 Formulation trials of middle active layer of nelfinavir. F. CODE Nelfinavir HPMC K4M HPMC K15M Guar Gum PVP K-30 MCC Mg Stearate TOTAL F F F F F F F F F F F F F F F F F F F F F F F F F F F Preparation of Upper and Lower Layers of Nelfinavir Trilayered Tablets The barrier layers were formulated employing hydrophobic swellable polymer polyox WSR 303 the swelling erosion modeling fillers which include water soluble MCC, EC and Xanthan gum. The procedure adopted to make the compacts was via direct compressions. For the first procedure the Polyox, xanthan gum and the filler were mixed in mortar and lubricated with magnesium stearate. Formulation of upper and lower layers was depicted in Table 2 (Wadher et al., 2011). TABLE 2 Composition of nelfinavir trilayered matrix tablet. INGREDIENTS AF8 BF8 CF8 DF8 EF8 FF8 GF8 HF8 MIDDILE ACTIVE LAYER (F8) (750 mg) Nelfinavir HPMC K 4 M HPMC K 15 M Guar Gum PVP K MCC Cellulose Magnesium stearate UPPER AND LOWER LAYER (100 mg) Polyox WSR Xanthan gum Ethyl cellulose MCC Magnesium stearate Talc Formulation of Extended Release Tryilayered Tablets of Nelfinavir The powder mixtures required for active and barrier layers were weighed accurately and thoroughly mixed using mortar and pestle for about 20 minutes. Initially, the volume of die cavity (12 mm, round) was adjusted equivalence to the weight of trilayered matrix tablets (950 mg). Then the pre-weighed amount of powder equivalent to bottom layer (100 mg) was taken and placed in the die cavity and slightly compressed for uniform spreading. The upper punch was lifted up and the granules equivalent to 750 mg of the drug was placed over the bottom layer in the die cavity and again slightly compressed. The remaining volume of the die cavity was filled with pre-weighed (100 mg) amount of powder equivalent to top layer and compressed with the full force of compression on rotary tablets press to obtain trilayered tablets (Table 2). Tri-layered matrix tablets of each composition were compressed and tested for their friability, Hardness, drug content and drug release characteristics with a suitable number of tablets for each test (Jalpar and Patel, 2011). Evaluation of Trilayer Matrix Tablets of Nelfinavir Hardness, Thickness, Friability, Weight variation: Hardness of ten randomly picked tablets was determined using Monsanto hardness tester.
3 Rangu and Gande: Formulation and Evaluation of Nelfinavir Extended Release Trilayer Matrix Tablets by Design of Thickness: The thickness of the tablets was measured using Vernier calipers. Friability: A sample of twenty randomly selected tablets were accurately weighed and placed in a Roche friabilator. The friabilator was operated for 4 min at a speed of 25 rpm. The tablets were removed from the friabilator, de-dusted and reweighed. The percent loss in weight due to abrasion and impact was calculated as, %Friability= (Loss in weight/ Initial weight) 100. Weight variation: The weight variation test was performed as per the I.P. guidelines. Twenty randomly taken tablets were weighed together and the average weight was determined. Each tablet was then weighed individually and deviation from average weight was calculated. Content uniformity: 20 tablets were randomly selected, and average weight was calculated. Tablets were powdered in a glass mortar. Powder equivalent to 10 mg was weighed and dissolved in 100mL of Phosphate buffer ph 6.8 filtered and drug content analyzed spectrophotometrically in UV spectrophotometer at 254 nm. In Vitro swelling studies: The degree of swelling of polymer is an important factor affecting adhesion. For conducting the study, a tablet was weighed and placed in a petri dish containing 5 ml of phosphate buffer ph 6.8 in 12 h at regular intervals of time (1, 2, 4, 8, 10 and 12 h), the tablet was taken carefully by using filter paper. The swelling index was calculated using the following formula Swelling Index (S.I) = (Wt Wo)/Wo 100 Where S.I = swelling index, Wt = weight of tablet after swollen at time t, Wo = weight of the initial tablet. In-vitro drug release profile: In vitro drug release studies for developed trilayer matrix tablets were carried out by using dissolution apparatus II paddle type (Electrolab TDL-08L). The drug release profile was studied in 900mL Phosphate buffer ph 6.8 at 37 ± 0.5 o C temperature. The amount of drug release was determined at different intervals up to 24h by UV visible spectrophotometer (Shimadzu UV 1800) at 254nm. Drug release kinetics: To describe the kinetics of the drug release from matrix tablet, mathematical models such as Zero-order, First order and Higuchi, models were used. The criterion for selecting the most appropriate model was chosen on the basis of the goodness-or fit test. Drug-Excipient Compatibility Studies Fourier Transform Infrared Spectroscopy (FTIR): FTIR spectra for pure drug, physical mixture and optimized formulations were recorded using a Fourier transform Infrared spectrophotometer. The analysis was carried out in Shimadzu-IR Affinity 1 Spectrophotometer. The samples were dispersed in KBr and compressed into disc/pellet by application of pressure. The pellets were placed in the light path for recording the IR spectra. The scanning range was cm 1 and the resolution was 1 cm 1. SEM studies: The surface and shape characteristics of Tablets were determined by scanning electron microscopy (SEM) (HITACHI, S-3700N). Photographs were taken and recorded at suitable magnification. Stability studies: The stability study of the formulated Nelfinavir trilayer tablets were carried out under different conditions according to ICH guidelines using stability chamber (REMI make). Accelerated Stability studies were carried out at 40 0 C / 75 % RH for the best formulations for 6 months. The tablets were characterized for the hardness, friability, drug content and cumulative % drug released during the stability study period. Results and Discussion Preparation of Middle Active Layer The matrix tablets of Nelfinavir were prepared without the barrier layers. All the formulation trails were subjected to in vitro dissolution to determine the release profiles. From the above results, among all the formulations the formulation F8 was decided as optimized formulation for active layer based on the highest drug release i.e ± 1.86 within 12hrs when compared with other preparations (Figure 1-4). Formulation F8 was choosen as active layer for further studies. The prepared trilayer tablets were shown in Figure 5 and the tablets were evaluated for different parameters and found to be within the limits and the results are summarized in Table 3. The drug content of all formulation is in between %; drug content depends on angle of repose because if the angle of repose was good then drug content is also uniform because if the flow property is good then the drug is evenly distributed in the formulation (Table 3). Fig. 1. In vitro dissolution studies of nelfinavir middle active layer tablets F1-F7.
4 4262 Int J Pharm Sci Nanotech Vol 11; Issue 5 September October 2018 Fig. 2. In vitro dissolution studies of nelfinavir middle active layer tablets F8-F13. Fig. 4. In vitro dissolution studies of nelfinavir middle active layer tablets F21-F27. Fig. 3. In vitro dissolution studies of nelfinavir middle active layer tablets F14-F20. TABLE 3 Physico-chemical evaluation properties of Nelfinavir trilayered tablets. F. CODE *Weight variation (mg) # Thickness (mm) #Hardness (Kg/Cm 2 ) #Friability (%) Fig. 5. Preparation of trilayer matrix tablets of nelfinavir. # Content uniformity (%) Swelling index (%) AF ± ± ± ± ± ± 0.76 BF ± ± ± ± ± ± 0.72 CF ± ± ± ± ± ± 0.64 DF ± ± ± ± ± ± 0.81 EF ± ± ± ± ± ± 1.03 FF ± ± ± ± ± ± 0.84 GF ± ± ± ± ± ± 0.72 HF ± ± ± ± ± ± 0.79 *Values are expressed in mean ± SD : (n=20) #Values are expressed in mean ± SD : (n=3) TABLE 4 In vitro Drug Release Profile for Prepared Extended release trilayered Tablet of Nelfinavir (AF8-HF8). Time (h) AF8 BF8 CF8 DF8 EF8 FF8 GF8 HF8 Marketed Product 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 0.18 TABLE 4 Contd
5 Rangu and Gande: Formulation and Evaluation of Nelfinavir Extendedd Release Trilayer Matrix Tablets by Design of Time (h) AF8 BF8 CF8 DF8 EF8 FF8 GF8 HF ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 1.35 Marketed Product ± ± ± ± ± ± 1.52 Fig. 7. First order plots for the optimized formulation of nelfinavir trilayered tablets. Fig. 8. Higuchi plots for the optimized formulation of nelfinavir trilayered tablets. Fig. 6. Zero order plots for the optimized formulation of nelfinavir trilayered tablets. Fig. 9. Korsmeyer-Peppas plots for the optimized formulation of nelfinavir trilayered tablets. Evaluation of Trilayer Matrix Tablets of Nelfinavir The Swelling study of trilayered matrix tablet of Nelfinavir was given in Table 8 showed that the swelling index of the tablet increases with increase in time up to 12 hours, this may be attributed to the fact that the erosion of biodegradable polymer Xanthan gum. This indicates that the drug will remain in intestinal region till drug is released completely from the delivery system and promotes evacuation after its release (Table 3). In vitro dissolution studies of trilayer matrix tablets of Nelfinavir: The release of Nelfinavir from different formulations was carried out and the results are depicted in Table 4. The trilayer tablets extended the drug release up to 24 hrs. The highest drug release was found in the formulation DF8 i.e 98.72% within 24 h. DF8 was found to be optimized formulation based on the dissolution and other evaluation parameters. The marketed product drug release was found to be 93.78% up to 24h. The results are shown in Table 4. Release Order Kinetics Release order kinetics for optimized (DF8) formulation: From the above results it is apparent that the regression coefficient value closer to unity in case of zero order plot i.e indicates that the drug release follows a zeroa lesser order mechanism (Table 5). This data indicates amount of linearity when plotted by the first order equation. Hence it can be concluded that the major mechanism of drug release follows zero order kinetics. Further, the translation of the data from the dissolution studies suggested possibility of under- the data in to various mathematical modelling such as standing the mechanism of drug release by configuring Higuchi and Korsmeyer-Peppas plots. Further the n value obtained from the Korsmeyer-Peppas plots i.e indicating non Fickian (anomalous) transport thus it projected that delivered its active ingredient by coupled diffusion and erosion (Figure 6-9). In vitro drug release order kinetics for marketed product: From the above results it is apparent that the regression coefficient value closer to unity in case of First order plot i.e indicates that the drug release follows a first order mechanism (Table No 5). This data indicates a lesser amount of linearity when plotted by the zero-
6 4264 Int J Pharm Sci Nanotech Vol 11; Issue 5 September October 2018 order equation. Hence it can be concluded that the major mechanism of drug release follows first order kinetics. TABLE 5 Release order kinetics of optimized and marketed product. S. No. Formulation Zero order First order Higuchi Model Korsmeyer- Peppas n R 2 R 2 R 2 Model R 2 1 DF Marketed Product Further, the translation of the data from the dissolution studies suggested possibility of understanding the mechanism of drug release by configuring the data in to various mathematical modelling such as Higuchi and Korsmeyer-Peppas plots. The n value obtained from the Korsemeyer-Peppas plots i.e indicating non-fickian (anomalous) transport thus it projected that delivered its active ingredient by coupled diffusion and erosion (Figure 10-13). Fig. 10. Zero order plots for the marketed product. Fig. 11. First order plot for the marketed product. Fig. 12. Higuchi plot for the marketed product. Fig. 13. Korsmeyer-Peppas plot for the marketed product. Design of experiment: This method is mainly used to explain the effect of one factor on other factor, whether this effect is significant or not, if significant how it influences the response. In this present work the effect of one factor (Guar Gum) on other two factors (HPMC K 4M, HPMC K 15M) is explained (Figure 14). In the above graph the effect of Guar Gum on % cumulative drug release is examined, and it clearly indicates that there is a very significant effect of Guar Gum on % cumulative drug release. The formulations with all 3 factors shown % cumulative drug release in between but when Guar Gum is removed from the formulations the maximum % CDR is near This is the effect of factor (Guar Gum) on response (Figure 15). There is a negligible effect on Swelling Index of formulations because all formulations have excellent Swelling property and there is slight influence on Swelling Index by Guar Gum. Characterization FT-IR: Overall there was no alteration in peaks of Nelfinavir pure drug (Figure 16) and optimized formulation (Figure 18), suggesting that there was no interaction between drug & excipients. FTIR spectrum of pure drug and other polymers are shown in (Figure 17). There is additional peak appearing or disappearing hence no significant changes in peaks of optimized formulation was observed when compared to pure drug indicating absence of any interaction. SEM studies: SEM further confirmed both diffusion and erosion mechanisms to be operative during drug release from the optimized formulation (DF8). Initially, tablet matrix showed swelling with pore formation that is clearly visible from SEM image. At the end of 24 h, the matrix was intact, and pores had formed through it. SEM images also show the formation of gel structure indicating swelling and pore formation on the tablet surface (Figure 19). Stability studies: Optimized formulation DF8 was selected for stability studies on the basis of high cumulative % drug release. Stability studies were conducted for 6 months according to ICH guidelines. From these results it was concluded that, optimized formulation is stable and retained their original properties with minor differences.
7 Rangu and Gande: Formulation and Evaluation of Nelfinavir Extended Release Trilayer Matrix Tablets by Design of Fig. 14. Response surface plot showing the influence of amount of polymer on the release profile of nelfinavir for percent cumulative drug release. Fig. 15. Response surface plot showing the influence of amount of polymer on swelling index of nelfinavir. Fig. 16. FT-IR spectrum of pure drug nelfinavir.
8 4266 Fig. 17. FT-IR spectrum of nelfinavir physical mixture. Fig. 18. FT-IR spectrum of optimized formulation DF8. Fig. 19. SEM studies for optimised DF8. Int J Pharm Sci Nanotech Vol 11; Issue 5 September October 2018
9 Rangu and Gande: Formulation and Evaluation of Nelfinavir Extended Release Trilayer Matrix Tablets by Design of Conclusions It was concluded that trilayer matrix tablets of Nelfinavir could be successfully prepared by direct compression technique using different polymers combination. Based on the evaluation parameters, drug dissolution profile and release drug kinetics DF8 was found to be optimized formulation. Nelfinavir tablets were prepared by direct compression and consist of middle active layer with different grades of HPMC, MCC and PVP K30, upper and lower layers were prepared with Polyox WSR 303, Xanthan gum, microcrystalline cellulose, ethyl cellulose and Magnesium stearate. The tablets were also evaluated for physicochemical characteristics and release kinetics. The physicochemical characteristics of the prepared tablets were satisfactory. The developed drug delivery systems showed prolonged drug release rates over a period of 24 h. The release profile of the optimized formulation (DF8) was described by the zero-order and Higuchi model. The results indicate that the approach used could lead to a successful development of an extended release formulation of the drug. These results also demonstrated the suitability of three-layered tablet formulation of Nelfinavir to provide controlled release for prolonged period of time and improved linearity for Nelfinavir in comparison to marketed product in the effective management of AIDS with patient compliance. References Abdu S and Poddar SS (2004). A flexible technology for modified release of drugs multi layered tablets. J Control Rel 97: Colombo P, Conte U, Gazzaniga A, Maggi L, Sangalli M. E and Peppas N (1990). Drug release modulation by physical restrictions of matrix swelling. Int J Pharm 63: Conte U, Maggi L, Colombo P and La Manna A (1993). Multi-layered hydrophilic matrices as constant release devices. J Control Rel 26: Derakhshandeh K and Soleymani M (2010). Formulation and in vitro evaluation of nifedipine controlled release tablet: Influence of combination of hydrophilic and hydrophobic matrix forms. Asian J Pharmaceutics 4(4): Hong Wen and Kinam Park (2010). Oral controlled release formulation design and drug delivery. Theory to practice edited by Wiley publication, New Jersey Gohel MC, Parikh RK, Padshala MN, Sarvaiya KG and Jena DG (2007). Formulation and optimization of directly compressible isoniazid modified release matrix tablet. Ind J Pharm Sci, 69(5): Jalpar R and Patel Bhavik A (2011). Formulation and evaluation of oral controlled drug delivery system for a model anti diabetic drug Metformin. Int J Curr Pharma Res 3(2): Potturi PV and Sudhakar Y (2015). Formulation and in vitro/ in vivo evaluation of controlled release Entacapone trilayer matrix tablets by geomatrix. Int J Drug Delivery 7: Sinko P.J (2007). Martin s Physical Pharmacy and Pharmaceutical Sciences. Published by Wolters Kluwer Health Pvt. Ltd, New Delhi 5: Talukdar MM, Mooter VD, Augustijns P, Maga TT, Verbeke N and Kinget R (1998). In vitro evaluation of xanthan gum as potential excipients for oral controlled release matrix tablet formulation. Int J Pharm 169: Talukdar MM and Vercammen JP (1993). Evaluation of xanthan gum as a hydrophilic matrix for controlled release dosage forms. Drug Dev Ind Pharm 19: Tobyn MJ, Stani forth JN and Baichwal AR (1996). Prediction of physical properties of a novel polysaccharide-controlled release system. Int J Pharm 128: Wadher KJ, Kakde RB and Umekar M (2011). Formulation of sustained release metformin hydrochloride matrix tablets: Influence of hydrophilic polymers on the release rate and in vitro evaluation. Inter J Res Control Rel 1(1): Yihong Q, Chidambaram N and Kolette F (1998). Design and evaluation of layered diffusional matrices for zero order sustained-release tablets. J Control Rel 51: Address correspondence to: Rangu Nirmala, Associate Professor, Surabhi Dayakar Rao College of Pharmacy, Rimmanaguda (Vill), Gajwel (Mdl), Siddipet District, Gajwel, Telangana , India. Mob: rangunirmala@gmail.com
Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL
Volume: 2: Issue-3: July-Sept -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL Ajaykumar Patil*, Ashish Pohane, Ramya Darbar, Sharanya Koutika, Alekhya
More informationFormulation and Development of Sustained Release Tablets of Valsartan Sodium
INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of
More informationJournal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011
ISSN: 223-7346 Research Article Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp -394-43, Oct -Dec 211 FORMULATION AND INVITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE
More informationFeasibility of using natural gums for development of sustained release matrix tablet of itopride
Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 215, 7 (3):114-123 (http://scholarsresearchlibrarycom/archivehtml) ISSN 975-571 USA CODEN: DPLEB4 Feasibility
More informationDESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN
Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI
More informationA Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac
Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*
More informationAsian Journal of Research in Biological and Pharmaceutical Sciences
Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com APPLICATION OF FACTORIAL DESIGN AND OPTIMIZATION OF GLIMEPIRIDE SUSTAINED
More informationFABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS
Int. J. Chem. Sci.: 7(4), 2009, 2555-2560 FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS HINDUSTAN ABDUL AHAD *, B. PRADEEP KUMAR, C.
More informationVenkateswara Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)
Design and development of Metformin hydrochloride Tried sustained release tablets Venkateswara Rao T 1 *, Bhadramma N 1, Raghukiran CVS 2 and Madubabu K 3 Bapatla College of Pharmacy, Bapatla, Guntur-522101
More informationMaisammaguda, Dulapally, Secundrabad.
121 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(6): November-December 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY
More informationFORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS G. Subba Rao
More informationSTABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS
Int. J. Chem. Sci.: 8(1), 2010, 405-414 STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS V. L. NARASAIAH, T. KARTHIK KUMAR, D. SRINIVAS, K. SOWMYA, P. L. PRAVALLIKA and Sk. Md. MOBEEN
More informationFORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD
Int. J. Chem. Sci.: 6(3), 2008, 1270-1275 FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD K. P. R. CHOWDARY, P. TRIPURA SUNDARI and K. SURYA
More informationJournal of Global Trends in Pharmaceutical Sciences. Journal home page:
ISSN: 2230-7346 G Sridhar Babu et al. / JGTPS/ 5(4)-(2014) 2085-2092 (Research Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com FORMULATION AND IN-VITRO CHARACTERIZATION
More informationEVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data
EVALUATION OF EFFERVESCENT FLOATING TABLETS 6.1 Technological characteristics of floating tablets 6.2 Fourier transform infrared spectroscopy (FT-IR) 6.3 Differential scanning calorimetry (DSC) 6.4 In
More informationPreparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums
1368 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue 1 April-June 211 Research Paper International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue
More informationAvailable Online through Research Article
ISSN: 0975-766X Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF GASTRORETENTIVE TABLETS FOR CONTROLLED DELIVERY OF NORFLOXOCIN Ganesh Kumar Gudas*, Subal Debnath,
More informationFORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 4, Suppl 5, 212 FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE
More informationOptimization of valsartan tablet formulation by 2 3 factorial design
Research Article ISSN: 0974-6943 K. P. R. Chowdary et al. / Journal of Pharmacy Research 2014,8(9, Available online through http://jprsolutions.info Optimization of valsartan tablet formulation by 2 3
More informationOPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
Digest Journal of Nanomaterials and Biostructures Vol. 9, No. 3, July September 2014, p. 1077-1084 OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
More informationSTUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS
Int. J. Chem. Sci.: 10(4), 2012, 1934-1942 ISSN 0972-768X www.sadgurupublications.com STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS K. VENUGOPAL * and K. P. R. CHOWDARY a Nirmala College
More informationDesign and In-vitro Evaluation of Silymarin Bilayer Tablets
CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin
More informationFORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES
Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(3):159-164 Studies on formulation and in vitro evaluation
More informationEffect of Polymer Concentration and Viscosity Grade on Atenolol Release from Gastric Floating Drug Delivery Systems
Effect of Polymer Concentration and Viscosity Grade on Atenolol Release from Gastric Floating Drug Delivery Systems 1 1 1 2 U.V. Bhosale*, V. Kusum Devi, Nimisha Jain and P.V. Swamy 1 Al-Ameen College
More informationFORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.1, No.4, pp 1381-1385, Oct-Dec 2009 FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS
More informationSivakasi , Tamil Nadu, India. ABSTRACT KEYWORDS:
276 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 4(1): January-February 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
More informationInternational Journal of Medicine and Pharmaceutical Research
International Journal of Medicine and Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijmpr Research Article Open Access Formulation and Evaluation of Gastroretentive Floating
More informationFORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE
ISSN: 2395 1338 FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE B. Venkateswara Reddy *, K. Navaneetha Department of Pharmaceutics, St.Paul s College
More informationFormulation and evaluation of sublingual tablets of lisinopril
Journal of GROVER Scientific & Industrial AGARWAL: Research FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF LISINOPRIL Vol. 71, June 2012, pp. 413-417 413 Formulation and evaluation of sublingual tablets
More informationFormulation and evaluation of oro-dispersible tablets of lafutidine
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More information5.1 STANDARD CURVES OF DRUGS USED
223 Glipizide and Glimepiride matrix tablets were prepared by using Aloe barbadensis miller leaves mucilage, Guar gum, Povidone and were evaluated. Similarly Glipizide and Glimepiride transdermal patches
More informationFormulation and Evaluation of Bilayer Tablets of Glimepiride and Metformin HCL
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn: 2278-38, p-issn:2319-7676. Volume 9, Issue 1 Ver. IV (Jan. 214), PP 38-45 Formulation and Evaluation of Bilayer Tablets of Glimepiride
More informationDevelopment and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride
Development and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride R. Margret Chandira*, C.M. Sahu and B. Jayakar Department of Pharmaceutics Vinayaka Mission s College of
More informationFormulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium
Available online on www.ijddt.com International Journal of Drug Delivery Technology 214; (3); 98-13 Research Article ISSN: 97 441 Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast
More informationPatel Krunal M et al. IRJP 2 (2)
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 223 87 Available online http://www.irjponline.com Research Article DESIGN DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE TABLET OF MONTELUKAST SODIUM BY
More informationInt. Res J Pharm. App Sci., 2013; 3(2): ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(2):112-116 Research Article FORMULATION AND EVALUATION
More informationCHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR
CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR Efavirenz and ritonavir, two widely prescribed anti retroviral
More informationFormulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting
Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting Biresh Kumar Sarkar* 1, Devananda Jain 1, Mamta Parwal 2 1. Bhagwant University, Dept.of Pharmaceutical Tech and Sciences,
More informationFormulation and Evaluation
Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the
More informationThe Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation
METHOCEL Premium Cellulose Ethers Application Data The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation INTRODUCTION Hydrophilic matrices
More informationFormulation and Evaluation of Bilayer Tablet by Wet Granulation
ABSTRACT: Formulation and Evaluation of Bilayer Tablet by Wet Granulation Nishith Patel 1, Kanu R Patel 2, Rakesh kumar Jat 3 1 Research Scholar, JJT University, Jhunjhunu, Rajasthan, India 2 Asso. Professor,
More informationInternational Journal of Research in Pharmacy and Science
Research article Available online www.ijrpsonline.com ISSN: 2249 3522 International Journal of Research in Pharmacy and Science Formulation and Evaluation of Floating Tablet of Metoprolol Tartrate Patel
More informationFORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES
Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER 407 - PVPK30 INCLUSION COMPLEXES K.P.R. Chowdary*, K. Surya Prakasa
More informationDEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING MATRIX TABLETS OF METFORMIN HYDROCHLORIDE
ISSN: 0975-8232 IJPSR (2010), Vol. 1, Issue 8 (Research article) Received 11 April, 2010; received in revised form 17 June, 2010; accepted 13 July, 2010 DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED
More informationResearch Article Formulation and In-Vitro Evaluation of Fast Disintegrating Rosiglitazone Sublingual Tablets
Research Article Formulation and In-Vitro Evaluation of Fast Disintegrating Rosiglitazone Sublingual Tablets Bhanja Satyabrata *, Hardel Danendra K and Sudhakar Muvvala Department of Pharmaceutics, Malla
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLETS OF METFORMIN HYDROCHLORIDE R.Margret Chandira*, P.Palanisamy,
More informationFormulation and In-vitro Evaluation of Sumatriptan succinate Bilayer Tablets
Formulation and In-vitro Evaluation of Sumatriptan succinate Bilayer Tablets M. Sunitha Reddy 1, B. Sharath Reddy 1, S. Muhammed Fazal Ul Haq 1 Centre of Pharmaceutical Sciences, Jawaharlal Nehru Technological
More informationFORMULATION AND IN VITRO EVALUATION OF VALSARTAN SUSTAINED RELEASE TABLETS USING TAMARIND SEED POLYSACCHARIDE
ISSN: 2230-7346 Yajaman Sudhakar et al. / JGTPS / 6(2)-(2015) 2589 2595 (Research Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com FORMULATION AND IN VITRO
More informationFormulation Development and Evaluation of Modified Release Tablet using a Fixed Dose Combination of Antidiabetic Agents
Research Article Formulation Development and Evaluation of Modified Release Tablet using a Fixed Dose Combination of Antidiabetic Agents Nishit Gohel 1*, D M Patel 2, Komal Patel 3, Jignasa Modi 4 1 School
More informationFormulation development of Glipizide matrix tablet using different proportion of natural and semi synthetic polymers
Pharm Methods, 2017; 8(1): 45-53 A multifaceted peer reviewed journal in the field of Pharm Analysis and Pharmaceutics www.phmethods.net www.journalonweb.com/phm Research Article Formulation development
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 211, 3(2):786-791 Development and optimization of colon targeted
More informationInt. J. Pharm. Sci. Rev. Res., 28(1), September October 2014; Article No. 21, Pages:
Research Article V.T. Iswariya 1 *, A Hariom Prakash Rao 1, V Lokeswara Babu 1, Mohd Abdul Hadi 1, A Srinivasa Rao 2 1 Dept. of Pharmaceutics, Bhaskar Pharmacy College, Bhaskar Nagar, Yenkapally (V), Moinabad
More informationResearch Article Formulation and Evaluation of Dual Component Tablets of Metoprolol tartrate
Research Article Formulation and Evaluation of Dual Component Tablets of Metoprolol tartrate Rashmin N. Patel 1 * and Praful D. Bharadia 2 Department of Pharmaceutics, B. S. Patel Pharmacy College, Saffrony
More informationAsian Journal of Biochemical and Pharmaceutical Research
ISSN: 2231-2560 Research Article Asian Journal of Biochemical and Pharmaceutical Research Design and Evaluation of Gastroretentive Floating Tablets of Dipyridamole: Influence of Formulation Variables A.
More informationAsian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012
STUDIES ON EFFECT OF SUPERDISINTEGRANTS ON ETORICOXIB TABLET FORMULATIONS Chowdary K. P. R 1, Venugopal. K *2 1 College of Pharmaceutical Sciences, Andhra University, Vishakapattanam. 2 * Nirmala college
More informationScholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3 (6):24-30 (http:scholarsresearchlibrary.comarchive.html) ISSN 0974-248X USA CODEN: DPLEB4 Formulation
More informationFormulation and In vitro Release Characterization of Metoprolol Succinate Extended Release Tablets
Sakthikumar et al: Formulation and In vitro Release Characterization of Metoprolol Succinate Extended Release Tablets 1537 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue
More informationAsian Journal of Research in Biological and Pharmaceutical Sciences Journal home page:
Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com DESIGN, DEVELOPMENT AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM
More informationFormulation and evaluation of immediate release salbutamol sulphate
5 Formulation, optimization and evaluation of immediate release layer of salbutamol sulphate Salbutamol is moderately selective beta (2)-receptor agonist similar in structure to terbutaline and widely
More informationFORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS
International Journal of PharmTech Research CODEN( USA): IJPRIF ISSN : 0974-4304 Vol.1, No.3, pp 634-638, July-Sept 2009 FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS K. Reeta Vijaya
More informationMuniyandy SARAVANAN,*,a Kalakonda SRI NATARAJ, a and Kettavarampalayam Swaminath GANESH b
978 Notes Chem. Pharm. Bull. 51(8) 978 983 (2003) Vol. 51, No. 8 Hydroxypropyl Methylcellulose Based Cephalexin Extended Release Tablets: Influence of Tablet Formulation, Hardness and Storage on in Vitro
More informationDesign and development of guar gum and borax crosslinked guar gum matrix tablets of theophylline for colon specific drug
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(2):1052-1060 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Design and development of guar gum and borax crosslinked
More informationBahadur S. et al /J. Pharm. Sci. & Res. Vol.1(4), 2009,
Abstract: In the present work, we developed an effective mucoadhesive tablets of omeprazole(diomeprazole magnesium powder and omeprazole pellets) by direct punch method with excellent mucoadhesive force
More informationFormulation and Evaluation of Metronidazole Enteric Coated Tablets for Colon Targeting
Human Journals Research Article May 2015 Vol.:3, Issue:2 All rights are reserved by Srilakshmi N et al. Formulation and Evaluation of Metronidazole Enteric Coated Tablets for Colon Targeting Keywords:
More informationFormulation Development and Evaluation of Sitagliptin Floating Tablets Containing Natural Polymer
Human Journals Research Article May 2015 Vol.:3, Issue:2 All rights are reserved by Tanvi P Gunjal et al. Formulation Development and Evaluation of Sitagliptin Floating Tablets Containing Natural Polymer
More informationInt. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION
More informationPharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs
Mansoura University Faculty of Pharmacy Department of Pharmaceutics Pharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs Thesis presented by Ali Saeed
More informationFORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.2, No.1, pp 341-347, Jan-Mar 1 FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS Kothawade S. N. 1 *, Kadam
More informationPreparation and Evaluation of Gastro Retentive Floating Tablets of Atorvastatin Calcium
Preparation and Evaluation of Gastro Retentive Floating Tablets of Atorvastatin Calcium Florida Sharmin 1, Md. Abdullah Al Masum 1, S. M. Ashraful Islam 1 and Md. Selim Reza 2 1 Department of Pharmacy,
More informationBilayer Tablets: Atorvastatin Calcium Nanoparticles and Clopidogrel Bisulfate Sustained Release Formulation. S. Subramanian, J.
ORIGINAL ARTICLE Bilayer Tablets: Atorvastatin Calcium Nanoparticles and Clopidogrel Bisulfate Sustained Release Formulation S. Subramanian, J. Tharini Department of Pharmaceutics, PSG College of Pharmacy,
More informationFormulation Development and Evaluation of Sustained Release Matrix Tablets of Guaiphenesin
3312 Int J Pharm Sci Nanotech Vol 9; Issue 3 May June 2016 International Journal of Pharmaceutical Sciences and Nanotechnology Research Paper Volume 9 Issue 3 May June 2016 MS ID: IJPSN-4-6-16-BASARKAR
More informationPreparation And Optimisation Of Valsartan Bilayered Sustained Release Matrix Tablets
ISSN 976 3333 Available Online at www.ijpba.info. International Journal of Pharmaceutical & Biological Archives 211; 2(3):914-92 ORIGINAL RESEARCH ARTICLE Preparation And Optimisation Of Valsartan Bilayered
More informationFabrication and evaluation of Nimesulide Azadirachta indica fruit mucilage based sustained release matrix tablets
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.2, No.2, pp 937-941, April-June 2010 Fabrication and evaluation of Nimesulide Azadirachta indica fruit mucilage based
More informationPREPARATION AND INVITRO EVALUATION OF RABEPRAZOLE SODIUM DELAYED RELEASE ENTERIC COATED TABLETS
Page1000 Indo American Journal of Pharmaceutical Research, 2014 ISSN NO: 2231-6876 Journal home page: http:///index.php/en/ INDO AMERICAN JOURNAL OF PHARMACEUTICAL RESEARCH PREPARATION AND INVITRO EVALUATION
More informationDESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG M Seth *, DS Goswami,
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Formulation And Invitro Evaluation Of Sustained Release Matrix Tablets Of Ibuprofen S Shanmugam, T Vetrichelvan and P Niranjan* Adhiparasakthi
More informationDesign and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets
Research Reviews: Pharmacy & Pharmaceutical Sciences e-issn: 2320-1215 www.rroij.com Design and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets Sowjanya Battu*, Madhavi K, Bhikshapathi
More informationOptimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS
CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS 5.1. AIM OF THE STUDY The pulsatile type press coated colon targeted atenolol tablet release drug after 6 hr lag time. The compression coated
More informationFormulation and evaluation of gastro retentive floating tablets of Terbutaline sulphate
Formulation and evaluation of gastro retentive floating tablets of Terbutaline sulphate Lokesh Kumar*, Virendra Singh, Rakesh Kumar Meel Department of Pharmaceutics, Goenka College of Pharmacy, NH-11,
More informationVolume: I: Issue-3: Nov-Dec ISSN
Volume: I: Issue-3: Nov-Dec -2010 ISSN 0976-4550 DESIGN AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE BASED ON COMBINATION OF NATURAL AND SYNTHETIC POLYMERS Hindustan Abdul Ahad 1,
More informationJournal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(1):320-328 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development of modified release tablet dosage forms
More informationThis PDF is available for free download from a site hosted by Medknow Publications
26 CMYK Research Paper Possible Use of Psyllium Husk as a Release Retardant ANGIRA DESAI, SUPRIYA SHIDHAYE*, V. J. KADAM Department of Pharmaceutics, Bharati Vidhyapeeth s College of Pharmacy, Sector-8,
More informationBioadhesive Polymer Buccal Tablets for Losartan Potassium Controlled Delivery: Formulation, In-vitro and Ex-vivo Evaluation
American Journal of Advanced Drug Delivery www.ajadd.co.uk Original Article Bioadhesive Polymer Buccal Tablets for Losartan Potassium Controlled Delivery: Formulation, In-vitro and Ex-vivo Evaluation T.
More informationDevelopment And Evaluation Of Gastroretentive Floating Tablet Of Rosuvastatin
Development And Evaluation Of Gastroretentive Floating Tablet Of Rosuvastatin Amiya kumar Prusty, Archana P. Chand Institute of Pharmacy and Technology, salipur, Biju Patnaik University of technology,
More informationInternational Journal of Chemistry and Pharmaceutical Sciences
Ramesh Naik M et al IJCPS, 2014, Vol.2(11): 1259-1264 Research Article ISSN: 2321-3132 International Journal of Chemistry and Pharmaceutical Sciences Fabrication and Evaluation of Montelukastsodium Sustained
More informationDesign and Evaluation of Atenolol Floating Drug Delivery System
Available online on www.ijcpr.com International Journal of Current Pharmaceutical Review and Research, 4(1), 1-26 Research Article ISSN: 976-822X Design and Evaluation of Atenolol Floating Drug Delivery
More informationFormulation and evaluation of sustained release atenolol
9 Formulation, optimization and evaluation of sustained release layer of atenolol Atenolol is a cardioselective β-blocker widely prescribed for asymptomatic condition such as hypertension. It is poorly
More informationFORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN
FORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN Pranjal Kumar Singh*, Sanjoo Kumar, T.S.Easwari, V.K.Shukla, Guru Sharan Department of Pharmaceutics, IIMT College of Medical
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com ENHANCEMENT OF SOLUBILITY OF RITONAVIR BY USING SOLID DISPERSION TECHNIQUE 1 K.Sai Saran*, 2 M.Srujan Kumar, 3 Dr.K.V.Subrahmanyam
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3(1): 38-44 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationFORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Suppl 1, 2012 Research Article FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING
More informationVol-3, Issue-4, Suppl-1, Nov 2012 ISSN: Patel et al PHARMA SCIENCE MONITOR
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES FORMULATION AND IN-VITRO EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF DOMPERIDONE Rahul B. Patel *, K. R. Patel, M. R. Patel, N.
More informationDESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL
DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL Isha Shah, Alpesh Yadav, Shailendra Bhatt Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-3000. Abstract
More informationFORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND GLIMEPIRIDE
Research Article Ghanshyam Patel,, 2012; Volume 1(6): 75-87 ISSN: 2277-8713 FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND GLIMEPIRIDE -QR CODE GHANSHYAM PATEL 1, Dr. RAGIN
More informationA FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS
Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar
More informationInternational Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : Vol.2, No.2, pp , April-June 2010
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.2, No.2, pp 834-841, April-June 2010 Modulating the Release Behavior and Kinetic Evaluation of Diclofenac Sodium from
More informationFORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES
Research Article Deshmukh ND,, 2012; Volume 1(5): 364-378 ISSN: 2277-8713 FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES *N. D. DESHMUKH, R. R.
More informationMODULATION OF GASTROINTESTINAL TRANSIT TIME OF SALBUTAMOL SULPHATE BY FLOATING APPROCHES
Pooja et al Journal of Drug Delivery & Therapeutics; 213, 3(3), 37-41 37 Available online at http://jddtonline.info RESEARCH ARTICLE MODULATION OF GASTROINTESTINAL TRANSIT TIME OF SALBUTAMOL SULPHATE BY
More informationFORMULATION AND EVALUATIONOF AMOXYCILLIN: THREE-LAYER GUAR GUM MATRIX TABLET
Gupta and Singh, IJPSR, 2013; Vol. 4(7): 2683-2690. ISSN: 0975-8232 IJPSR (2013), Vol. 4, Issue 7 (Research Article) Received on 05 March, 2013; received in revised form, 29 April, 2013; accepted, 29 June,
More information